adorable baby smiling with joy
Peds Calc

PedsCalc Pro

No ads, plus saved calculations and notes in the Pro app.

$19.99/year, about $1.67/month. Cancel anytime.

Safety & Interactions

Cefdinir Drug InteractionsWhat to avoid, adjust, and monitor

Cefdinir is well tolerated in pediatrics, but its absorption and elimination are easily influenced by common over-the-counter products and chronic medications. Because many of these agents are also used in children (iron, antacids, laxatives, asthma medications), it is critical to anticipate interactions up front. The main safety themes are protecting oral bioavailability, preventing additive nephrotoxicity, watching for coagulation changes, and counseling families about harmless side effects like stool discoloration. Thoughtful scheduling and monitoring can prevent most clinically significant problems.

7 Interactions
0 High-Risk
5 Moderate
2 Low/Mild
Back to Cefdinir Overview

Overview

Cefdinir is well tolerated in pediatrics, but its absorption and elimination are easily influenced by common over-the-counter products and chronic medications. Because many of these agents are also used in children (iron, antacids, laxatives, asthma medications), it is critical to anticipate interactions up front. The main safety themes are protecting oral bioavailability, preventing additive nephrotoxicity, watching for coagulation changes, and counseling families about harmless side effects like stool discoloration. Thoughtful scheduling and monitoring can prevent most clinically significant problems.

Key Takeaways Before Prescribing

  • Screen for iron supplements, multivitamins, and antacids at every visit—timing fixes most absorption problems.
  • Review nephrotoxic and renally cleared co-medications in medically complex children; adjust cefdinir interval for reduced kidney function.
  • Educate caregivers about orange-red stools when iron and cefdinir are co-administered so they do not confuse it with GI bleeding.
  • Check INR or anti-factor Xa levels when combining cefdinir with vitamin K antagonists or direct oral anticoagulants (DOACs) in adolescents.
  • Pause live oral vaccines until antibacterial therapy is completed to preserve vaccine efficacy.

High-Risk Combinations to Screen

Review severity, mechanism, and management for common interaction partners. Counsel families on when to pause therapy and when to seek urgent care.

Iron supplements and fortified multivitamins

ModerateFerrous sulfate, Ferrous fumarate, Polysaccharide iron complex, Prenatal vitamins

Mechanism: Bivalent cations chelate cefdinir in the gut lumen, cutting bioavailability by up to 80% and causing rust-colored, non-bloody stools as the iron–drug complex is excreted.

Management: Administer cefdinir at least 2 hours before or after iron-containing products. If separation is impossible, consider extending therapy 1–2 extra days to reach equivalent exposure.

Monitoring: Assess clinical response (fever curve, symptom relief) after 48–72 hours; lack of improvement may signal poor absorption.

Parent tips: Warn caregivers that stools can turn brick-red when iron and cefdinir mix—this is benign unless accompanied by pain or black, tarry stool.

Pediatric considerations: Premature infants and toddlers on chronic iron therapy are at greatest risk because they often receive dosing via bottles around the same time as antibiotics.

Laboratory monitoring: None typically required

Aluminum- or magnesium-based antacids and sucralfate

ModerateMagnesium hydroxide, Aluminum hydroxide, Sucralfate, Magnesium/aluminum hydroxide combinations

Mechanism: Aluminum and magnesium bind cefdinir, delaying gastric emptying and reducing peak serum concentrations.

Management: Avoid co-administration; separate cefdinir by at least 2 hours before or after antacids or sucralfate. For reflux control, consider famotidine or proton pump inhibitors which do not reduce exposure.

Monitoring: Track symptom resolution. Consider therapeutic substitution if repeated separation is impractical for families.

Parent tips: If a child needs rapid relief from heartburn, offer a short-term alternative like calcium carbonate while maintaining the 2-hour window for cefdinir.

Pediatric considerations: Children with feeding tubes often receive sucralfate for esophagitis—flag the interaction in tube-feeding schedules.

Probenecid and renal tubular secretion inhibitors

ModerateProbenecid, Aspirin (high dose), Cimetidine

Mechanism: Competition for renal tubular secretion raises cefdinir AUC and prolongs half-life, increasing risk for diarrhea and, rarely, seizures in renal impairment.

Management: Avoid intentional combination in pediatrics. If unavoidable, ask the prescriber or pharmacist whether the cefdinir dose or interval needs to change, and monitor renal labs.

Monitoring: Serum creatinine, BUN, sedation level, and stool frequency in medically complex children.

Parent tips: Encourage extra hydration and report new lethargy or reduced urine output promptly.

Pediatric considerations: Children with tumor lysis protocols occasionally receive probenecid—coordinate with oncology pharmacists before starting cefdinir.

Laboratory monitoring: Serum creatinine, BUN

Anticoagulants and antiplatelet agents

ModerateWarfarin, Apixaban, Rivaroxaban, Clopidogrel

Mechanism: Disruption of vitamin K–producing gut flora and potential platelet function effects can raise bleeding risk.

Management: Obtain baseline INR (for warfarin) or monitor for bruising and mucosal bleeding in adolescents on DOACs. Adjust anticoagulant dosing if INR rises >0.5 above target.

Monitoring: INR or anti-Xa levels within 3–5 days of starting therapy; reinforce bleeding precautions.

Parent tips: Teach families to watch for new nosebleeds, gum bleeding, or prolonged menstrual flow and to call the clinic if these occur.

Pediatric considerations: Children with congenital heart disease or mechanical valves may rely on precise anticoagulation—coordinate with cardiology.

Nephrotoxic agents

ModerateAminoglycosides, Vancomycin, NSAIDs (high dose), Cyclosporine, Tacrolimus

Mechanism: Additive renal stress may reduce cefdinir clearance and precipitate acute kidney injury, especially in dehydrated children.

Management: Ensure adequate hydration, review daily fluid goals, and consider extending cefdinir interval to every 24 hours in reduced eGFR.

Monitoring: Serum creatinine every 48–72 hours in hospitalized patients; watch urine output and weight in outpatients.

Parent tips: Encourage liberal fluids and prompt reporting of decreased urination or swelling.

Pediatric considerations: Solid-organ transplant recipients and oncology patients frequently take calcineurin inhibitors—consult the specialty pharmacist when layering antibiotics.

Laboratory monitoring: Serum creatinine, Urinalysis

Live attenuated oral vaccines

MinorTy21a oral typhoid vaccine, Oral cholera vaccine

Mechanism: Antibacterial therapy reduces vaccine organism replication, decreasing immunogenicity.

Management: Delay live oral vaccines until at least 3 days after cefdinir is completed; if vaccination already occurred, revaccinate with an inactivated formulation when available.

Monitoring: Document vaccination date and antibiotic course in the EHR for future reference.

Parent tips: Explain that injectable vaccines are unaffected; only oral live vaccines need rescheduling.

Pediatric considerations: Travel clinics should double-check antibiotic plans for adolescents preparing for international trips.

Laboratory glucose tests (non-enzymatic assays)

MinorClinitest, Benedict's solution

Mechanism: Cefdinir metabolites can cause false-positive urine glucose readings with copper reduction tests.

Management: Use enzymatic glucose oxidase tests while cefdinir is prescribed; reinforce this with families of children who have diabetes.

Monitoring: Review home glucose logs for inconsistencies; confirm with finger-stick testing if urine results are unexpected.

Parent tips: Label urine test supplies with a reminder to hold testing or use alternate strips until antibiotics are finished.

Pediatric considerations: Important for children with type 1 diabetes or metabolic disorders undergoing home ketone/glucose monitoring.

Monitoring Checklist

  • Document a full supplement list—including toddler multivitamins and fortified formulas—before prescribing.
  • Schedule follow-up or telehealth touchpoints within 72 hours for high-risk infections if iron or antacids cannot be separated.
  • Trend renal function in children with chronic kidney disease, transplant, or concurrent nephrotoxins.
  • Recheck INR or anti-Xa levels after cefdinir is introduced in anticoagulated adolescents.
  • Record vaccine deferrals in the immunization registry when cefdinir delays oral travel vaccines.

Caregiver Counseling Tips

  • Give cefdinir with a full glass of water and avoid mixing it in the same cup as iron-fortified formula or vitamin drops.
  • If your child needs an antacid, offer it at least 2 hours apart from the antibiotic and keep a medication log to stay on track.
  • Expect harmless rust-colored stools when iron and cefdinir overlap; call immediately for black tarry stool or vomiting blood.
  • Maintain hydration—aim for pale-yellow urine—and call the clinic for reduced urination or puffy eyes.
  • Tell your pharmacist and specialists (cardiology, oncology, nephrology) that your child is taking cefdinir so they can adjust other medicines if needed.

Evidence & References

  1. Cefdinir Capsules and Oral Suspension — Prescribing Information (U.S. National Library of Medicine, 2024, Label)
  2. Cefdinir (MedlinePlus, 2024, Drug Monograph)
  3. Cefdinir: Pediatric Drug Information (Lexicomp, 2025, Drug Monograph)
  4. Timing and Spacing of Immunobiologics (Centers for Disease Control and Prevention, 2024, Guideline)
  5. Cefdinir (Rx) Drug Interactions (Medscape, 2025, Drug Interaction)